Advanced Search
  • Aug 28, 2014
    Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins

    DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial...

  • Aug 28, 2014
    First U.S. Growth Guidance System Cleared to Treat Scoliosis with Children's Needs in Mind

    MEMPHIS, TN - Aug. 28, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of...

  • Aug 27, 2014
    NGC's Hospital Managed Services Business Adds to Medtronic's Growing Healthcare Services and Solutions Portfolio

    TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction...

  • Aug 27, 2014
    Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT

    MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...

  • Aug 26, 2014
    Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position

    MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...